After hinting COVID-19 drug Pemgarda might not work against new strains, the FDA announced the medication is effective against KP.3.1.1, the dominant variant.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
After hinting COVID-19 drug Pemgarda might not work against new strains, the FDA announced the medication is effective against KP.3.1.1, the dominant variant.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis